REGULATORY

• New Measures Needed to Ramp Up Generic Use: Chuikyo
  August 10, 2017

• MHLW Orders Label Revisions for Warfarin, 3 Other APIs
  August 7, 2017

• (Update) Katsunobu Kato Tapped as New Health Minister
  August 4, 2017

• Clinical Research Law to Apply to “Nearly All Drug-Related Clinical Research” Funded by Drug Makers: MHLW
  August 4, 2017

• Katsunobu Kato Tapped as New Health Minister
  August 3, 2017

• “We Should Increase Our Efforts” to Promote Pharmaceutical Industry: New Health Policy Bureau Chief Takeda
  August 3, 2017

• MHLW Advisory Panel Recommends Approval for Zetia/Lipitor Combo
  August 3, 2017

• Bayer’s ADR Reporting Delay “Very Regrettable”: Shiozaki
  August 2, 2017

• Will “Emphasize Exchange of Views” to Tackle Challenges: Pharma Bureau Chief Miyamoto
  August 1, 2017

• MHLW to Support Healthcare-Related Startups from “Long-Term Perspective”: Health Minister Shiozaki
  August 1, 2017

• Drug Pricing Overhaul Must Strike Balance between Benefits and Costs: Health Insurance Bureau Chief
  July 31, 2017

• Govt to Discuss Platforms to Promote Expansion of Drug Makers into Emerging Markets
  July 31, 2017

• MHLW Advisory Panel Backs Approval of Pfizer’s Palbociclib
  July 28, 2017

• MHLW Council Recommends Switching of 4 APIs; Switching of Levonorgestrel for Emergency Contraception Disapproved
  July 28, 2017

• Chuikyo Scrutiny Continues for Cost Calculation Pricing Formula
  July 27, 2017

• Chuikyo Members at Odds over How to Proceed with “CEA” Debate
  July 27, 2017

• Govt OKs Basic Policy for FY2018 Budget Requests
  July 21, 2017

• Panel OKs 42.12 Million Yen Price Tag for Drug Makers’ MID-NET Use in PMS
  July 20, 2017

• MHLW Panel to Discuss Zetia + Lipitor Combination Product on Aug. 1
  July 20, 2017

• Shiozaki Says MHLW to Uphold 3-Year 1.5 Trillion Yen Cap in Social Security Cost Rise, CEFP Panelists Call for Further Curtailment
  July 19, 2017

ページ

• « 先頭
• ‹ Prev
• …
• 239
• 240
• 241
• 242
• 243
• 244
• 245
• 246
• 247
• …
• Next ›
• 最終 »